Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses

The novel coronavirus SARS-CoV-2 is damaging the world’s social and economic fabrics seriously. Effective drugs are urgently needed to decrease the high mortality rate of COVID-19 patients. Unfortunately, effective antiviral drugs or vaccines are currently unavailable. Herein, we systematically eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guobing, Ruan, Shasha, Zhao, Xiaolu, Liu, Qi, Dou, Yali, Mao, Fengbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719282/
https://www.ncbi.nlm.nih.gov/pubmed/33312453
http://dx.doi.org/10.1016/j.csbj.2020.11.056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719282/
https://www.ncbi.nlm.nih.gov/pubmed/33312453
http://dx.doi.org/10.1016/j.csbj.2020.11.056

Ejemplares similares